Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
All Favorites
#
Name
Description
Category
Type
Source
Website
TEN
Spain – Electronic auction services – Sistema dinámico de adquisición de servicios de subastas electrónicas para la enajenación de bienes en desuso de la DG de Contratación y Servicios del Ayuntamiento de Madrid (2 categorías).
ted.europa.eu
Buyer: Área de Gobierno de Economía, Innovación y Hacienda del Ayuntamiento de Madrid | Notice type: cn-standard | Procedure: restricted | Contract: s...
TenderProcurement ContractSpainOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: Área de Gobierno de Economía, Innovación y Hacienda del Ayuntamiento de Madrid | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-06-30
TEN
Czechia – Laboratory, optical and precision equipments (excl. glasses) – Dynamický nákupní systém na laboratorní a měřicí techniku (III.)
ted.europa.eu
Buyer: Západočeská univerzita v Plzni | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-30
TenderProcurement ContractCzechiaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: Západočeská univerzita v Plzni | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-30
TEN
Germany – Dressings – Verbandmittel-Verträge ab 01.08.2025 im Rahmen eines Open-House-Verfahrens
France – Electric vehicles – 25MC0165AOR-SYSTEME D'ACQUISITION DYNAMIQUE - ACQUISITION ET AMENAGEMENTS DE VEHICULES PEU EMISSIFS (électriques et hybrides) Années 2025 à 2027
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Interferon beta-1a (ATC-Code nach WHO: L03AB07)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform PEN (ATC-Code nach WHO: L03AX13)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform Fertigspritze (ATC-Code nach WHO: L03AX13)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
TEN
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Bimatoprost (ATC-Code nach WHO: S01EE03)
ted.europa.eu
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJun 30, 2027
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
TEN
Lithuania – Mobile telephones – Mobiliųjų telefonų aparatų nuomos užsakymai per CPO LT elektroninį katalogą
Ireland – Education and training services – LI3747C Request to Participate in a Panel for the Provision of eBooks to the Education and Training Boards (ETBs) network of schools and centres
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)
ted.europa.eu
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varel...
TenderProcurement ContractGermanyOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 1, 2027
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
TEN
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
TenderProcurement ContractLithuaniaOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 1, 2027
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
GRA
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
grants.gov
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate...
GrantCash GrantUnited StatesOpen
AmountNot provided on the source page. Please check the official source.
DeadlineJul 2, 2027
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
No saved opportunities on this page
Use the star icon near an opportunity title to add it to Favorites.
📅 Best viewed on desktop - or rotate your phone to landscape mode.
#
Opportunity
Type
Region / Country
Amount
Deadline
Source
42701
Spain – Electronic auction services – Sistema dinámico de adquisición de servicios de subastas electrónicas para la enajenación de bienes en desuso de la DG de Contratación y Servicios del Ayuntamiento de Madrid (2 categorías).Buyer: Área de Gobierno de Economía, Innovación y Hacienda del Ayuntamiento de Madrid | Notice type: cn-standard | Procedure: rest...
Tender
Procurement Contract
Spain
Not provided on the source page. Please check the official source.
Buyer: Área de Gobierno de Economía, Innovación y Hacienda del Ayuntamiento de Madrid | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-06-30
42702
Czechia – Laboratory, optical and precision equipments (excl. glasses) – Dynamický nákupní systém na laboratorní a měřicí techniku (III.)Buyer: Západočeská univerzita v Plzni | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-...
Tender
Procurement Contract
Czechia
Not provided on the source page. Please check the official source.
France – Electric vehicles – 25MC0165AOR-SYSTEME D'ACQUISITION DYNAMIQUE - ACQUISITION ET AMENAGEMENTS DE VEHICULES PEU EMISSIFS (électriques et hybrides) Années 2025 à 2027Buyer: Toulouse Métropole | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-06-30
Tender
Procurement Contract
France
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Formoterol/Glycopyrronium/Budesonid (ATC-Code nach WHO: R03AL11)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
42713
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Interferon beta-1a (ATC-Code nach WHO: L03AB07)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
42714
Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform PEN (ATC-Code nach WHO: L03AX13)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
42715
Germany – Pharmaceutical products – Abschluss nicht exkl. AM-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Glatirameracetat in der Darreichungsform Fertigspritze (ATC-Code nach WHO: L03AX13)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
42716
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Bimatoprost (ATC-Code nach WHO: S01EE03)Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-06-30
Ireland – Education and training services – LI3747C Request to Participate in a Panel for the Provision of eBooks to the Education and Training Boards (ETBs) network of schools and centresBuyer: Education Procurement Service (EPS) | Notice type: cn-social | Procedure: restricted | Contract: services | Deadline: 2027-...
Tender
Procurement Contract
Ireland
Not provided on the source page. Please check the official source.
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd...
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 61964069711 Fax: +49 6966816559711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
42723
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-VerfahrensBuyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
Tender
Procurement Contract
Germany
Not provided on the source page. Please check the official source.
Buyer: AB „Kelių priežiūra“ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-07-01
42725
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical...
Grant
Cash Grant
United States
Not provided on the source page. Please check the official source.
This notice of funding opportunity (NOFO) provides funding to conduct efficacy studies in an established rare disease preclinical model to demonstrate that a proposed therapeutic agent warrants further development. In addition to preclinical efficacy, accompanying pharmacodynamic and pharmacokinetic studies would be supported. Therapeutic agents include small molecules, biologics or biotechnology-derived products. The goal of this NOFO is to spur therapeutic development for a variety of rare diseases by advancing projects to the point where they would attract subsequent investment supporting full Investigational New Drug (IND) application development or progression to clinical trials in the case of repurposing or repositioning.
No saved opportunities on this page. Use the star icon near an opportunity title.
